Prevalence of Vitamin D Deficiency and Effects of Supplementation With Cholecalciferol in Patients With Chronic Kidney Disease

Journal of Renal Nutrition

Volumn 24, Issue 1, 2014, Pages 20-25

  Kim, Sun Moon ^a   Choi, Hyung Jin ^a   Lee, Jung Pyo ^b,c   Kim, Dong Ki ^b   Oh, Yun Kyu ^b,c   Kim, Yon Su ^b   Lim, Chun Soo ^b,c  

^a Chungbuk National University Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Seoul National University Boramae Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

COLECALCIFEROL; VITAMIN D;

AGED; ARTICLE; BLOOD; CHRONIC KIDNEY FAILURE; DIET SUPPLEMENTATION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; PROSPECTIVE STUDY; STATISTICAL MODEL; VITAMIN D DEFICIENCY;

AGED; CHOLECALCIFEROL; DIETARY SUPPLEMENTS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84890430476     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2013.07.003     Document Type: Article

References (21)

1. LaClair R.E., Hellman R.N., Karp S.L., et al. Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States. Am J Kidney Dis 2005, 45:1026-1033.
2. Oh Y.J., Kim M., Lee H., et al. A threshold value of estimated glomerular filtration rate that predicts changes in serum 25-hydroxyvitamin D levels: 4th Korean National Health and Nutritional Examination Survey 2008. Nephrol Dial Transplant 2012, 27:2396-2403.
3. Mehrotra R., Kermah D., Budoff M., et al. Hypovitaminosis D in chronic kidney disease. Clin J Am Soc Nephrol 2008, 3:1144-1151.
4. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003, 42(suppl 3):S1-S201. National Kidney Foundation.
5. Cheriet S., Royer M., Rajzbaum G., Tremollières F. Vitamin D supplementation in patients with chronic kidney disease. Joint Bone Spine 2012, 79(suppl 2):S110-S113.
6. Figuiredo-Dias V., Cuppari L., Garcia-Lopes M.G., de Carvalho A.B., Draibe S.A., Kamimura M.A. Risk factors for hypovitaminosis D in nondialyzed chronic kidney disease patients. J Ren Nutr 2012, 22:4-11.
7. Judd S.E., Tangpricha V. Vitamin D therapy and cardiovascular health. Curr Hypertens Rep 2011, 13:187-191.
8. Kamen D.L., Tangpricha V. Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity. J Mol Med (Berl) 2010, 88:441-450.
9. Pilz S., Iodice S., Zittermann A., Grant W.B., Gandini S. Vitamin D status and mortality risk in CKD: a meta-analysis of prospective studies. Am J Kidney Dis 2011, 58:374-382.
10. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl 2009, 76:S1-S130. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group.
11. Cuppari L., Garcia-Lopes M.G. Hypovitaminosis D in chronic kidney disease patients: prevalence and treatment. J Ren Nutr 2009, 19:38-43.
12. Garcia-Lopes M.G., Pillar R., Kamimura M.A., et al. Cholecalciferol supplementation in chronic kidney disease: restoration of vitamin D status and impact on parathyroid hormone. Ann Nutr Metab 2012, 61:74-82.
13. Vilarrasa N., Maravall J., Estepa A., et al. Low 25-hydroxyvitamin D concentrations in obese women: their clinical significance and relationship with anthropometric and body composition variables. J Endocrinol Invest 2007, 30:653-658.
14. Wortsman J., Matsuoka L.Y., Chen T.C., Lu Z., Holick M.F. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000, 72:690-693.
15. Kim M.J., Frankel A.H., Donaldson M., et al. Oral cholecalciferol decreases albuminuria and urinary TGF-β1 in patients with type 2 diabetic nephropathy on established renin-angiotensin-aldosterone system inhibition. Kidney Int 2011, 80:851-860.
16. Al-Aly Z., Qazi R.A., González E.A., Zeringue A., Martin K.J. Changes inserum 25-hydroxyvitamin D and plasma intact PTH levels following treatment with ergocalciferol in patients with CKD. Am J Kidney Dis 2007, 50:59-68.
17. Zisman A.L., Hristova M., Ho L.T., Sprague S.M. Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease. Am J Nephrol 2007, 27:36-43.
18. Chandra P., Binongo J.N., Ziegler T.R., et al. Cholecalciferol (vitamin D3) therapy and vitamin D insufficiency in patients with chronic kidney disease: a randomized controlled pilot study. Endocr Pract 2008, 14:10-17.
19. Kandula P., Dobre M., Schold J.D., Schreiber M.J., Mehrotra R., Navaneethan S.D. Vitamin D supplementation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials. Clin J Am Soc Nephrol 2011, 6:50-62.
20. Oh J., Wunsch R., Turzer M., et al. Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 2002, 106:100-105.
21. Briese S., Wiesner S., Will J.C., et al. Arterial and cardiac disease in young adults with childhood-onset end-stage renal disease-impact of calcium and vitamin D therapy. Nephrol Dial Transplant 2006, 21:1906-1914.